CN108244272A - 一种用于不同疾病人群的油脂组合物及其制备方法 - Google Patents
一种用于不同疾病人群的油脂组合物及其制备方法 Download PDFInfo
- Publication number
- CN108244272A CN108244272A CN201810213288.9A CN201810213288A CN108244272A CN 108244272 A CN108244272 A CN 108244272A CN 201810213288 A CN201810213288 A CN 201810213288A CN 108244272 A CN108244272 A CN 108244272A
- Authority
- CN
- China
- Prior art keywords
- oil
- composition
- fat
- grease
- epa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 151
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 24
- 201000010099 disease Diseases 0.000 title abstract description 12
- 235000019198 oils Nutrition 0.000 claims abstract description 128
- 235000019197 fats Nutrition 0.000 claims abstract description 88
- 239000004519 grease Substances 0.000 claims abstract description 88
- 235000021323 fish oil Nutrition 0.000 claims abstract description 79
- 206010061218 Inflammation Diseases 0.000 claims abstract description 25
- 230000004054 inflammatory process Effects 0.000 claims abstract description 25
- 230000006641 stabilisation Effects 0.000 claims abstract description 13
- 238000011105 stabilization Methods 0.000 claims abstract description 13
- 230000002265 prevention Effects 0.000 claims abstract description 11
- 239000003205 fragrance Substances 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims description 124
- 239000002253 acid Substances 0.000 claims description 47
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 19
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 12
- 206010020772 Hypertension Diseases 0.000 claims description 12
- 235000019501 Lemon oil Nutrition 0.000 claims description 12
- 235000013793 astaxanthin Nutrition 0.000 claims description 12
- 239000001168 astaxanthin Substances 0.000 claims description 12
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 12
- 229940022405 astaxanthin Drugs 0.000 claims description 12
- 239000010501 lemon oil Substances 0.000 claims description 12
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 10
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 10
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 10
- 125000001931 aliphatic group Chemical group 0.000 claims description 10
- 235000005687 corn oil Nutrition 0.000 claims description 10
- 239000002285 corn oil Substances 0.000 claims description 10
- 235000012661 lycopene Nutrition 0.000 claims description 10
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 10
- 229960004999 lycopene Drugs 0.000 claims description 10
- 239000001751 lycopene Substances 0.000 claims description 10
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 9
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 9
- 239000004006 olive oil Substances 0.000 claims description 9
- 235000008390 olive oil Nutrition 0.000 claims description 9
- 239000008165 rice bran oil Substances 0.000 claims description 9
- 239000003813 safflower oil Substances 0.000 claims description 9
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical group COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 9
- 239000008169 grapeseed oil Substances 0.000 claims description 8
- 235000020688 green tea extract Nutrition 0.000 claims description 8
- 229940094952 green tea extract Drugs 0.000 claims description 8
- 239000000944 linseed oil Substances 0.000 claims description 8
- 235000021388 linseed oil Nutrition 0.000 claims description 8
- 235000004347 Perilla Nutrition 0.000 claims description 7
- 244000124853 Perilla frutescens Species 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 239000010502 orange oil Substances 0.000 claims description 7
- 239000003549 soybean oil Substances 0.000 claims description 7
- 235000012424 soybean oil Nutrition 0.000 claims description 7
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 6
- 235000019502 Orange oil Nutrition 0.000 claims description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 6
- 229940011037 anethole Drugs 0.000 claims description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 6
- 229940093503 ethyl maltol Drugs 0.000 claims description 6
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 6
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims description 6
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 6
- 235000019498 Walnut oil Nutrition 0.000 claims description 5
- 239000008170 walnut oil Substances 0.000 claims description 5
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- 208000029078 coronary artery disease Diseases 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 3
- 239000005770 Eugenol Substances 0.000 claims description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 3
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 3
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 235000021342 arachidonic acid Nutrition 0.000 claims description 3
- 229940114079 arachidonic acid Drugs 0.000 claims description 3
- 229960002217 eugenol Drugs 0.000 claims description 3
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 3
- 229960002733 gamolenic acid Drugs 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- 206010067268 Post procedural infection Diseases 0.000 claims description 2
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 2
- 235000019477 peppermint oil Nutrition 0.000 claims description 2
- 230000002980 postoperative effect Effects 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 208000037902 enteropathy Diseases 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000028774 intestinal disease Diseases 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract description 84
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract description 43
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract description 43
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract description 42
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 235000019634 flavors Nutrition 0.000 abstract description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 3
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 16
- 230000002526 effect on cardiovascular system Effects 0.000 description 13
- 238000007789 sealing Methods 0.000 description 12
- 102000016893 Amine Oxidase (Copper-Containing) Human genes 0.000 description 9
- 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 description 9
- 229930003427 Vitamin E Natural products 0.000 description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 235000019165 vitamin E Nutrition 0.000 description 8
- 229940046009 vitamin E Drugs 0.000 description 8
- 239000011709 vitamin E Substances 0.000 description 8
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- 150000002978 peroxides Chemical class 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 6
- 230000000474 nursing effect Effects 0.000 description 6
- 229940068065 phytosterols Drugs 0.000 description 6
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 6
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000008524 evening primrose extract Nutrition 0.000 description 5
- 239000010475 evening primrose oil Substances 0.000 description 5
- 229940089020 evening primrose oil Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001631 hypertensive effect Effects 0.000 description 5
- 235000011073 invertase Nutrition 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 150000003180 prostaglandins Chemical class 0.000 description 5
- 230000035488 systolic blood pressure Effects 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 244000246386 Mentha pulegium Species 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 3
- 235000004357 Mentha x piperita Nutrition 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000001050 hortel pimenta Nutrition 0.000 description 3
- 239000001573 invertase Substances 0.000 description 3
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- CUXYLFPMQMFGPL-BGDVVUGTSA-N (9Z,11E,13Z)-octadecatrienoic acid Chemical compound CCCC\C=C/C=C/C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-BGDVVUGTSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000000055 hyoplipidemic effect Effects 0.000 description 2
- 229940088592 immunologic factor Drugs 0.000 description 2
- 239000000367 immunologic factor Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XNRNNGPBEPRNAR-JQBLCGNGSA-N thromboxane B2 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1OC(O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O XNRNNGPBEPRNAR-JQBLCGNGSA-N 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 206010014498 Embolic stroke Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 101000889557 Rattus norvegicus Amiloride-sensitive amine oxidase [copper-containing] Proteins 0.000 description 1
- 101000983193 Rattus norvegicus D-amino-acid oxidase Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010067130 Spastic diplegia Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000005027 intestinal barrier Anatomy 0.000 description 1
- 230000007358 intestinal barrier function Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- CUXYLFPMQMFGPL-UYWAGRGNSA-N trichosanic acid Natural products CCCCC=C/C=C/C=CCCCCCCCC(=O)O CUXYLFPMQMFGPL-UYWAGRGNSA-N 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | 造模后 | 第一周 | 第二周 | 第三周 | 第四周 |
正常组 | 118.23±7.56a | 116.19±2.78a | 117.12±8.35a | 115.96±9.56a | 118.29±5.63a |
实验组-1 | 184.16±8.23a | 175.98±5.63a | 158.23±5.89b | 147.32±5.63c | 135.68±2.45d |
实验组-2 | 186.25±4.97a | 174.68±6.13a | 147.23±5.14b | 139.32±7.26c | 121.46±4.65d |
实验组-3 | 183.12±4.02a | 171.23±5.13a | 150.23±5.01b | 149.32±6.23c | 132.68±3.78d |
对照组-1 | 186.13±9.13a | 185.76±6.98a | 182.23±5.36a | 178.56±5.42a | 168.98±5.28b |
对照组-2 | 185.67±6.73a | 185.01±4.89a | 181.96±6.73a | 176.53±5.96a | 169.46±5.37b |
对照组-3 | 184.39±5.93a | 183.79±5.83a | 182.18±7.16a | 180.37±6.73a | 172.48±4.85b |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810213288.9A CN108244272A (zh) | 2018-03-15 | 2018-03-15 | 一种用于不同疾病人群的油脂组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810213288.9A CN108244272A (zh) | 2018-03-15 | 2018-03-15 | 一种用于不同疾病人群的油脂组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108244272A true CN108244272A (zh) | 2018-07-06 |
Family
ID=62745748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810213288.9A Pending CN108244272A (zh) | 2018-03-15 | 2018-03-15 | 一种用于不同疾病人群的油脂组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108244272A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109805108A (zh) * | 2019-03-29 | 2019-05-28 | 江南大学 | 一种炎性肠病特殊医学用途配方食品脂肪组件及其制备方法 |
CN110881660A (zh) * | 2019-11-13 | 2020-03-17 | 安徽济生元药业有限公司 | 一种鱼油软胶囊及其制备方法 |
WO2020119165A1 (zh) * | 2018-12-10 | 2020-06-18 | 瞿瀚鹏 | Dha油脂组合物在凝胶糖果中的应用以及凝胶糖果及其制备方法 |
CN111436611A (zh) * | 2020-04-27 | 2020-07-24 | 新绎健康管理有限公司 | 含复合不饱和脂肪酸的组合物 |
CN112674335A (zh) * | 2020-12-31 | 2021-04-20 | 山东蓝奥生物技术有限公司 | 一种添加虾青素的保健油及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101142947A (zh) * | 2007-09-24 | 2008-03-19 | 张国浩 | 一种含鱼油或多烯鱼油的营养均衡调和油及其生产方法 |
CN108041184A (zh) * | 2017-12-20 | 2018-05-18 | 山东朱氏药业集团有限公司 | 一种预防和治疗心血管疾病的混合油脂 |
-
2018
- 2018-03-15 CN CN201810213288.9A patent/CN108244272A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101142947A (zh) * | 2007-09-24 | 2008-03-19 | 张国浩 | 一种含鱼油或多烯鱼油的营养均衡调和油及其生产方法 |
CN108041184A (zh) * | 2017-12-20 | 2018-05-18 | 山东朱氏药业集团有限公司 | 一种预防和治疗心血管疾病的混合油脂 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020119165A1 (zh) * | 2018-12-10 | 2020-06-18 | 瞿瀚鹏 | Dha油脂组合物在凝胶糖果中的应用以及凝胶糖果及其制备方法 |
CN109805108A (zh) * | 2019-03-29 | 2019-05-28 | 江南大学 | 一种炎性肠病特殊医学用途配方食品脂肪组件及其制备方法 |
CN110881660A (zh) * | 2019-11-13 | 2020-03-17 | 安徽济生元药业有限公司 | 一种鱼油软胶囊及其制备方法 |
CN111436611A (zh) * | 2020-04-27 | 2020-07-24 | 新绎健康管理有限公司 | 含复合不饱和脂肪酸的组合物 |
CN112674335A (zh) * | 2020-12-31 | 2021-04-20 | 山东蓝奥生物技术有限公司 | 一种添加虾青素的保健油及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108244272A (zh) | 一种用于不同疾病人群的油脂组合物及其制备方法 | |
US10071073B2 (en) | Compositions containing as the active ingredient components from Salvia sclarea seed | |
JP7007010B2 (ja) | 脂質含有組成物およびその使用方法 | |
JP4031219B2 (ja) | 油脂組成物 | |
Mishra et al. | Cooking oils for heart health | |
DE60038682T2 (de) | Fettzusammensetzungen | |
DE60112635T2 (de) | Ölzusammensetzung und ihre Verwendung | |
CN103380827B (zh) | 一种预防肥胖性脂肪肝的油脂组合物及其制备方法 | |
CN108041184A (zh) | 一种预防和治疗心血管疾病的混合油脂 | |
WO2002011550A2 (en) | Oil/fat composition | |
JPWO2010052847A1 (ja) | 濃厚流動食 | |
JPWO2003074043A1 (ja) | 体温上昇剤 | |
CN101099562A (zh) | Ω-3系不饱和脂肪酸类佐餐油及其生产方法和应用 | |
CN105961633A (zh) | 一种牡丹籽油调和油及其制备方法 | |
JP2002302441A (ja) | 月経前症候群症状緩和用組成物及び飲食物 | |
CN113413342B (zh) | 一种从澳洲坚果中提取棕榈油酸的方法及其应用 | |
JP2018127452A (ja) | 炎症を伴う肝疾患の治療または予防剤 | |
CN108991140A (zh) | 一种中老年人专用调和油 | |
Lee | Essent ial Fat ty Acids | |
CN106260120A (zh) | 一种富硒食用调和油及其制备方法 | |
KR100684641B1 (ko) | 유지 조성물, 이를 함유하는 식품 및 건강보조식품 | |
JP3999914B2 (ja) | 油脂組成物 | |
Rodríguez et al. | Olive oil and other oils as a part of traditional diets and bioactive compounds for cardioprotection | |
JP2018070602A (ja) | 抗疲労食品組成物および抗疲労剤 | |
Kiritsakis et al. | Olive oil and health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 100176 Beijing Daxing District economic and Technological Development Zone, East District, thirteen Chuang thirteen street, two district, 7 Building 101 room. Applicant after: Beijing Nuokangda Pharmaceutical Technology Co.,Ltd. Address before: 100176 Beijing Daxing District economic and Technological Development Zone, East District, thirteen Chuang thirteen street, two district, 7 Building 101 room. Applicant before: BEIJING NUOKANGDA PHARMACEUTICAL TECHNOLOGY CO.,LTD. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201116 Address after: 102600 Daxing biomedical industry base, Zhongguancun Science Park, Daxing District, Beijing 0501-57-4 Applicant after: Beijing Connaught Pharmaceutical Co.,Ltd. Address before: 100176 Beijing Daxing District economic and Technological Development Zone, East District, thirteen Chuang thirteen street, two district, 7 Building 101 room. Applicant before: Beijing Nuokangda Pharmaceutical Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20210622 Address after: 100176 Beijing Daxing District economic and Technological Development Zone, East District, thirteen Chuang thirteen street, two district, 7 Building 101 room. Applicant after: Beijing Nuokangda Pharmaceutical Technology Co.,Ltd. Address before: 102600 Daxing biomedical industry base 0501-57-4, Zhongguancun Science and Technology Park, Daxing District, Beijing Applicant before: Beijing Connaught Pharmaceutical Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210816 Address after: 100176 room 108, first floor, building 7, zone 2, No. 31, Kechuang 13th Street, economic and Technological Development Zone, Daxing District, Beijing (Yizhuang group, high-end industrial area of Beijing Pilot Free Trade Zone) Applicant after: Beijing nuobao Nutrition Technology Co.,Ltd. Address before: 100176 Beijing Daxing District economic and Technological Development Zone, East District, thirteen Chuang thirteen street, two district, 7 Building 101 room. Applicant before: Beijing Nuokangda Pharmaceutical Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180706 |
|
RJ01 | Rejection of invention patent application after publication |